| Dorothy Jean Jackson, MD | |
|
3801 Blue Pkwy, Kansas City, MO 64130-2807 | |
| (816) 923-5800 | |
| Not Available |
| Full Name | Dorothy Jean Jackson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 3801 Blue Pkwy, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023004009 | NPI | - | NPPES |
| 201760055 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R8B55 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dorothy Jean Jackson, MD 3801 Blue Pkwy, Kansas City, MO 64130-2807 Ph: (816) 923-5800 | Dorothy Jean Jackson, MD 3801 Blue Pkwy, Kansas City, MO 64130-2807 Ph: (816) 923-5800 |
News Archive
Mild traumatic brain injuries (TBI) could be linked to eye movement impairment, even beyond the acute stage of injury, according to researchers at the Uniformed Services University of the Health Sciences.
The National Foundation for Infectious Diseases supports the Centers for Disease Control and Prevention's annual observance of National Influenza Vaccination Week to communicate the importance and availability of influenza vaccination into the winter months and beyond. It is critical that physicians and patients, especially parents of pediatric patients, remain vigilant about flu protection this and every year.
Scientists using machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school, identified clusters of learning difficulties which did not match the previous diagnosis the children had been given.
A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.
Johnson & Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.
› Verified 8 days ago
Maria Akram Sheikh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |